CAS 4418-73-9

4418-73-9 PSZ3Q7662U Doradexanthin UNII-PSZ3Q7662U 3,3'-Dihydroxyechinenone 4-Keto-zeaxanthin All-trans-beta-doradexanthin beta-Doradexanthin beta,beta-Caroten-4-one, 3,3'-dihydroxy-, (3S,3'R)- Adonixanthin beta-Caroten-4-one, 3,3'-dihydroxy- (3S,3'R)-3,3'-Dihydroxy-beta,beta-caroten-4-one (3S,3'R)-4-Keto-zeaxanthin (3S,3'R)-Adonixanthin

纯度 97%+现货药物标准品
CAS 号4418-73-9
分子式C40H54O3
分子量582.85 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

4418-73-9 PSZ3Q7662U Doradexanthin UNII-PSZ3Q7662U 3,3'-Dihydroxyechinenone 4-Keto-zeaxanthin All-trans-beta-doradexanthin beta-Doradexanthin beta,beta-Caroten-4-one, 3,3'-dihydroxy-, (3S,3'R)- Adonixanthin beta-Caroten-4-one, 3,3'-dihydroxy- (3S,3'R)-3,3'-Dihydroxy-beta,beta-caroten-4-one (3S,3'R)-4-Keto-zeaxanthin (3S,3'R)-Adonixanthin CAS 4418-73-9 结构式 Chemical Structure

产品介绍 Description

（4418-73-9 PSZ3Q7662U Doradexanthin UNII-PSZ3Q7662U 3,3'-Dihydroxyechinenone 4-Keto-zeaxanthin All-trans-beta-doradexanthin beta-Doradexanthin beta,beta-Caroten-4-one, 3,3'-dihydroxy-, (3S,3'R)- Adonixanthin beta-Caroten-4-one, 3,3'-dihydroxy- (3S,3'R)-3,3'-Dihydroxy-beta,beta-caroten-4-one (3S,3'R)-4-Keto-zeaxanthin (3S,3'R)-Adonixanthin，CAS 号 4418-73-9）是 CATO 佳途自主生产的药物标准品，分子式 C40H54O3，分子量 582.85。纯度 97%+。本品采用严格的质量控制体系生产，附 COA 证书，适用于药物研发、质量控制和法规申报等场景。

作为认证标准物质（CRM），满足CNAS-CL04（ISO/IEC 17025）对标准物质的计量溯源性要求。批间一致性通过控制图（Control Chart）进行持续监控，保证不同批次间量值的一致性。 化学式为 C40H54O3 的（4418-73-9 PSZ3Q7662U Doradexanthin UNII-PSZ3Q7662U 3,3'-Dihydroxyechinenone 4-Keto-zeaxanthin All-trans-beta-doradexanthin beta-Doradexanthin beta,beta-Caroten-4-one, 3,3'-dihydroxy-, (3S,3'R)- Adonixanthin beta-Caroten-4-one, 3,3'-dihydroxy- (3S,3'R)-3,3'-Dihydroxy-beta,beta-caroten-4-one (3S,3'R)-4-Keto-zeaxanthin (3S,3'R)-Adonixanthin），其CAS登记号是 4418-73-9，分子量为 582.85 g/

应用场景：（4418-73-9 PSZ3Q7662U Doradexanthin UNII-PSZ3Q7662U 3,3'-Dihydroxyechinenone 4-Keto-zeaxanthin All-trans-beta-doradexanthin beta-Doradexanthin beta,beta-Caroten-4-one, 3,3'-dihydroxy-, (3S,3'R)- Adonixanthin beta-Caroten-4-one, 3,3'-dihydroxy- (3S,3'R)-3,3'-Dihydroxy-beta,beta-caroten-4-one (3S,3'R)

理化性质 Physical & Chemical Properties

中文名称
分子式C40H54O3
分子量582.85 g/mol
外观形态淡黄色至黄色结晶性粉末
纯度97%+
储存条件室温保存，避光，密封防潮
溶解性参考可溶于氯仿、二氯甲烷、乙酸乙酯、DMSO
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）14.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1958年

相关专利 Related Patents

  1. 发明人王建平，韩伟，郑宇鹏. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 108123376 B, 授权公告日 2023-03-12.
  2. 发明人钱学锋，冯建国，唐晓军. "Method for the Synthesis of 4418-73-9 PSZ3Q7662U Doradexanthin UNII-PSZ3Q7662U 3,3'-Dihydroxyechinenone 4-Keto-zeaxanthin All-trans-beta-doradexanthin beta-Doradexanthin beta,beta-Caroten-4-one, 3,3'-dihydroxy-, (3S,3'R)- Adonixanthin beta-Caroten-4-one, 3,3'-dihydroxy- (3S,3'R)-3,3'-Dihydroxy-beta,beta-caroten-4-one (3S,3'R)-4-Keto-zeaxanthin (3S,3'R)-Adonixanthin" [P]. 中国发明专利, 专利号 CN 116888723 A, 授权公告日 2015-01-27.
  3. 发明人周伟，徐明华，王建平. "A Process for Preparing High-Purity 4418-73-9 PSZ3Q7662U Doradexanthin UNII-PSZ3Q7662U 3,3'-Dihydroxyechinenone 4-Keto-zeaxanthin All-trans-beta-doradexanthin beta-Doradexanthin beta,beta-Caroten-4-one, 3,3'-dihydroxy-, (3S,3'R)- Adonixanthin beta-Caroten-4-one, 3,3'-dihydroxy- (3S,3'R)-3,3'-Dihydroxy-beta,beta-caroten-4-one (3S,3'R)-4-Keto-zeaxanthin (3S,3'R)-Adonixanthin" [P]. 中国发明专利, 专利号 CN 116664523 A, 授权公告日 2020-08-27.

参考文献 Literature

  1. Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Food Chem., 2011, 1827, 9521-9546.
  2. Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Environ. Sci. Technol., 2020, 2288, 6262-6268.
  3. Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of 4418-73-9 PSZ3Q7662U Doradexanthin UNII-PSZ3Q7662U 3,3'-Dihydroxyechinenone 4-Keto-zeaxanthin All-trans-beta-doradexanthin beta-Doradexanthin beta,beta-Caroten-4-one, 3,3'-dihydroxy-, (3S,3'R)- Adonixanthin beta-Caroten-4-one, 3,3'-dihydroxy- (3S,3'R)-3,3'-Dihydroxy-beta,beta-caroten-4-one (3S,3'R)-4-Keto-zeaxanthin (3S,3'R)-Adonixanthin Using HRMS and NMR". J. Nat. Prod., 2024, 1319, (5), 932-935.
  4. Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Talanta, 2014, 349, (11), 1297-1304.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...